Humacyte Inc.
HUMA | NASDAQ
$0.58
-$0.01 (-1.69%)
Sep 22, 2026, 1:24 PM ET · Market open
Market Data
Market Cap $99.12M
Enterprise Value $85.4M
Beta 2.45
Average Volume 9.8M
Shares Outstanding (Diluted) 234.18M
Shares Change YoY 50.66%
Institutional Ownership 29.84%
Exchange NASDAQ
ISIN US44486Q1031
Price Performance
Price Change 1M -14.5%
Price Change 3M -15.8%
Price Change 6M -28.3%
Price Change YTD -39.5%
Price Change 1Y -66.7%
Price Change 3Y -79.5%
Price Change 5Y -95.3%
1M CAGR (ann.) -17.9%
1Y CAGR (ann.) -67.0%
5Y CAGR (ann.) -48.1%
All-Time CAGR -38.2%
Valuation
PE Ratio -1.16
Forward PE N/A
PEG Ratio 0.01
Forward PEG 0.03
PS Ratio 46.73
Forward PS 4.60
PB Ratio 3.17
P/FCF Ratio -1.02
P/Adj. FCF Ratio -0.92
P/OCF Ratio -1.40
EV/Sales 40.26
EV/EBIT -0.99
EV/EBITDA -1.07
EV/FCF -0.88
Earnings Yield -86.4%
FCF Yield -98.4%
Adj. FCF Yield -109.2%
Financial Health
Net Cash $43.58M
Total Debt $66.18M
Cash & Short-Term Investments $79.9M
Total Assets $138.09M
Current Ratio 6.21
Quick Ratio 5.74
Debt / Equity Ratio 2.12
Debt / EBITDA -0.83
Debt / FCF -0.68
OCF / Debt -1.47
Interest Coverage -10.80
Altman Z-Score -8.74
Piotroski F-Score 2
Margins & Profitability
Gross Profit Margin -666.8%
Operating Profit Margin -5240.8%
EBITDA Margin -3755.7%
Net Profit Margin -4560.8%
FCF Margin -4599.7%
Adj. FCF Margin -5104.6%
SBC / Revenue 504.9%
SBC Impact (per share) -11.0%
Returns
Return on Assets -70.0%
Return on Equity -938.2%
Return on Invested Capital -89.2%
Return on Capital Employed -90.3%
Return on Tangible Assets -70.0%
Historical Growth (CAGR)
Revenue CAGR 3Y 309.0%
Revenue CAGR 5Y 2.4%
Revenue CAGR 10Y N/A
EPS CAGR 3Y 50.7%
EPS CAGR 5Y -1.7%
EPS CAGR 10Y N/A
FCF CAGR 3Y -8.2%
FCF CAGR 5Y -5.2%
FCF CAGR 10Y N/A
Analyst Forecasts
Analyst Rating Buy
Analyst Count 11
EPS Growth Next 3Y 36.6%
Revenue Growth Next 3Y 369.2%
Earnings Date Nov 10, 2026
EPS Estimate (next Q) -$0.09
EPS Growth Est (next Q) -35.7%
Revenue Est (next Q) $769.38K
Revenue Growth Est (next Q) 2.2%
Fair Value Estimates
Graham Number N/A
Graham Upside N/A
Lynch Fair Value N/A
Lynch Upside N/A
Price Target $2
Price Target Upside 239.0%
Cash Flow
Operating Cash Flow $-97.19M
Free Cash Flow $-97.56M
Adj. Free Cash Flow $-108.27M
FCF Per Share -$0.42
OCF Per Share -$0.42
OCF/S Ratio -4582.4%
Income Statement
Revenue $2.12M
Gross Profit $-14.14M
Operating Income $-111.16M
EBITDA $-79.66M
Net Income $-96.74M
EPS (Diluted) -$0.51
Revenue / Employee $11.53K
Profit / Employee $-525.73K
Employees 184
Add to Watchlist
Select watchlists to add or remove HUMA